First Manhattan

First Manhattan’s Lexicon Pharmaceuticals LXRX Stock Holding History

First Manhattan’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,079	Closed	-$5K	–	1631
2021 Q3	$5K	Hold	1,079	–	–	﹤0.01%	1390
2021 Q2	$4K	Buy	+1,079	New	+$5.2K	﹤0.01%	1434
2019 Q3	–	Sell	-2,949,979	Closed	-$18.6M	–	1372
2019 Q2	$18.6M	Buy	2,949,979 +201,393	+7%	+$1.21M	0.1%	115
2019 Q1	$15.3M	Buy	+2,748,586	New	+$16.7M	0.09%	125
2018 Q2	–	Sell	-5,000	Closed	-$42K	–	1394
2018 Q1	$42K	Hold	5,000	–	–	﹤0.01%	982
2017 Q4	$49K	Hold	5,000	–	–	﹤0.01%	1007
2017 Q3	$61K	Hold	5,000	–	–	﹤0.01%	914
2017 Q2	$82K	Buy	+5,000	New	+$77.4K	﹤0.01%	845
2014 Q4	–	Sell	-41	Closed	–	–	1505
2014 Q3	$0	Buy	+41	New	+$438	﹤0.01%	1458

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return